insights_auto
Why is RLMD down 4,17%?
Dive Deeperchevron_right
RLMD:NASDAQ
Relmada Therapeutics Inc
3,34 USD
arrow_downward
-4,17%(-0,14) 1D
6-окт., 13:01:50 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RLMD...
Open
3,50 USD
High
3,50 USD
Low
3,27 USD
Mkt. cap
368,01 млн
Avg. vol.
1,18 млн
Volume
499,47 миң
52-wk high
8,00 USD
52-wk low
1,80 USD
EPS
-0,96 USD
Beta
0,51
Shares outstanding
106,67 млн
No. of employees
17
Open
3,50 USD
High
3,50 USD
Low
3,27 USD
Mkt. cap
368,01 млн
Avg. vol.
1,18 млн
Volume
499,47 миң
52-wk high
8,00 USD
52-wk low
1,80 USD
EPS
-0,96 USD
Beta
0,51
Shares outstanding
106,67 млн
No. of employees
17
News stories
From web sources and news partners
Benzinga
·
47 мүнөт мурун
BOXABL (NASDAQ: BXBL) Adds Former EY Audit Partner Timothy Goldsmith to Board as Audit Committee Chair
ChartMill
·
33 мүнөт мурун
Top movers in Tuesday's session
The Motley Fool
·
32 мүнөт мурун
Stock Market Midday, Oct. 6: S&P 500 Sets New High, Nuclear Stocks Surge
NBC News
·
2 саат мурун
S&P 500 hits record high as Nvidia nears $6 trillion milestone
About Relmada Therapeutics Inc
CEO-
Employees17
Founded2004
HeadquartersКорал Гейблс, Флорида, Америка Кошмо Штаттары
SectorPharmaceutical industry
Websiterelmada.com